ICG Enterprise Trust Outperformance through every stage of cycle – Hardman & Co (Interview)

ICG Enterprise Trust (LON:ICGT) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk. Mark talks gives us a summary of his 63 page report, explains why private equity is an attractive market, how ICGT adds value to this market, why it will out perform in a recession and the risks involved.

ICG Enterprise Trust plc is an investment company. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index of the largest listed companies. In particular it is one of the largest investment trusts on the stock exchange with a market capitalisation of £579 million as at 13 March 2020

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Hardman & Co

    More articles like this

    Fidelity Japan Trust

    Japanese stocks set to rise after reaching record highs

    After topping bubble-era highs, Goldman Sachs Research says Japanese stocks are poised to rise even higher. Japan’s Nikkei 225 stock index closed above 40,000 on March 4, setting another record high after climbing last month above

    Norcros Plc

    Norcros plc enhances Market Presence with Strategic Moves

    Norcros plc (LON:NXR), a prominent supplier of innovative bathroom and kitchen products, continues to make strategic moves to enhance its market presence and financial performance. The recent disposal of Johnson Tiles UK to its management team marks

    Accrol Group

    What are the latest technology trends in manufacturing?

    We asked the FactoryTech 50 and judging panel to describe a particular trend they have noticed in manufacturing technology in the last year. Judge Kevin Smith (below) is lead technology advisor at Made Smarter UK, which has engaged

    Team plc

    Key Insurance Types in Financial Planning

    When it comes to financial planning, different types of insurance serve different purposes. While critical illness insurance can be valuable, the importance of each insurance type may vary depending on a clients individual circumstances and priorities.

    Poolbeg Pharma granted significant POLB 001 patent in United States

    Poolbeg Pharma plc (LON:POLB, OTCQB:POLBF), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, has announced that, further to its announcement on 20 March 2024, the Company has received the fully granted